ArticleTheranostics2021

Aldehyde dehydrogenase inhibitors promote DNA damage in ovarian cancer and synergize with ATM/ATR inhibitors.

Edward Grimley et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.